Nazim Can Demircan (Nazım C Demircan, Nazim C Demircan, Nazım Can Demircan)
Publication Activity (10 Years)
Years Active: 2019-2022
Publications (10 Years): 7
Publications (10 Years): 7
Publications
- Nazim Can Demircan, Muhammet Mustafa Atcı, Metin Demir, Selver Işık, Baran Akagündüz
- Özkan Alan, Tuğba Akın Telli, Tugba Basoglu Tuylu, Rukiye Arikan, Nazim Can Demircan, Ozlem Ercelep, Serap Kaya, Nalan Akgul Babacan, Beste M Atasoy, Suheyla Bozkurt, Yasar Bayri, Dilek Gul, Gazanfer Ekinci, Ibrahim Ziyal, Faysal Dane, Perran Fulden Yumuk
- Tugba Basoglu Tuylu, Tuğba Akın Telli, Nazim Can Demircan, Rukiye Arikan, Ozlem Ercelep, Salih Ozguven, Sunullah Soysal, Asli Memisoglu, Faysal Dane, Perran Fulden Yumuk
- Özlem Ercelep, Özkan Alan, Tuğba Akın Telli, Tugba B Tuylu, Rukiye Arıkan, Nazim Can Demircan, Eda T Simsek, Nalan A Babacan, Serap Kaya, Faysal Dane, Emine Bozkurtlar, Tunc Ones, Tunc Lacin, Perran Fulden Yumuk
- Nazim Can Demircan, Özkan Alan, Tuğba Başoğlu Tüylü, Tuğba Akın Telli, Rukiye Arıkan, Furkan C Çiçek, Özlem Ercelep, Mehmet Akif Ozturk, İlknur Alsan Çetin, Rabia Ergelen, İlker Tinay, Nalan Akgül Babacan, Serap Kaya, Faysal Dane, Perran F YumukImpact of the Charlson Comorbidity Index on dose-limiting toxicity and survival in locally advanced and metastatic renal cell carcinoma patients treated with first-line sunitinib or pazopanib. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 26 (5) (2019)
- Tuğba Akın Telli, Nazim Can Demircan, Özkan Alan, Tugba B Tuylu, Rukiye Arikan, Ozlem Ercelep, Ali E Atıcı, Rabia Ergelen, Ipek E Seven, Nalan A Babacan, Serap Kaya, Faysal Dane, Perran Fulden Yumuk